| Segment Reporting |
The following table reflects results of operations of the Company’s reportable segment (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Infusion services net revenue | $ | 1,466,761 | | | $ | 1,411,051 | | | $ | 4,209,545 | | | $ | 4,115,240 | | | Other revenue (1) | 26,768 | | | 23,965 | | | 77,038 | | | 68,833 | | | Total Option Care Health revenue | 1,493,529 | | | 1,435,016 | | | 4,286,583 | | | 4,184,073 | | | (Expense) Income: | | | | | | | | | Cost of net revenues - drugs | (1,063,023) | | | (1,016,245) | | | (3,036,628) | | | (2,953,923) | | | Salaries, benefits, and other employee expense | (223,828) | | | (214,594) | | | (654,052) | | | (632,481) | | | Other segment items (2) | (99,342) | | | (103,379) | | | (298,523) | | | (302,986) | | | Depreciation and amortization expense | (18,120) | | | (16,291) | | | (50,479) | | | (48,278) | | | Interest expense, net | (12,875) | | | (14,146) | | | (40,199) | | | (41,824) | | | Equity in earnings of joint ventures | 1,523 | | | 2,176 | | | 4,916 | | | 5,300 | | | Other, net | 1,037 | | | (3,570) | | | 2,273 | | | (8,497) | | | Income tax expense | (21,468) | | | (17,151) | | | (57,202) | | | (52,303) | | | Net Income | $ | 57,433 | | | $ | 51,816 | | | $ | 156,689 | | | $ | 149,081 | |
(1) Represents business activities related to other miscellaneous revenue streams. (2) Other segment items includes expenses for medical supplies, delivery and packaging, leases, professional services, and other expenses.
|